Capital Management Corp VA Has $8.38 Million Stake in CME Group Inc. $CME

Capital Management Corp VA cut its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 6.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,407 shares of the financial services provider’s stock after selling 2,009 shares during the period. CME Group accounts for 1.4% of Capital Management Corp VA’s investment portfolio, making the stock its 28th largest holding. Capital Management Corp VA’s holdings in CME Group were worth $8,381,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. GQG Partners LLC grew its stake in CME Group by 7,676.3% during the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after purchasing an additional 2,176,685 shares during the period. Wellington Management Group LLP increased its stake in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after acquiring an additional 2,089,935 shares in the last quarter. Nuveen LLC bought a new stake in shares of CME Group in the 1st quarter valued at $218,842,000. Alliancebernstein L.P. lifted its position in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after acquiring an additional 808,740 shares during the period. Finally, Egerton Capital UK LLP boosted its stake in CME Group by 79.4% during the first quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock worth $459,003,000 after acquiring an additional 765,773 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a research report on Thursday, October 9th. TD Cowen upped their price target on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Finally, JPMorgan Chase & Co. upped their target price on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $283.71.

Get Our Latest Analysis on CME

CME Group Stock Down 1.5%

CME stock opened at $267.18 on Wednesday. The firm has a market capitalization of $96.29 billion, a PE ratio of 25.86, a P/E/G ratio of 6.23 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The stock’s 50 day moving average is $268.22 and its 200-day moving average is $271.32.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm posted $2.56 EPS. CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. Sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.40%.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last three months. 0.30% of the stock is owned by company insiders.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.